Do kids grow out of ADHD as they get older?

Attention-deficit hyperactivity disorder (ADHD) is more often diagnosed in children. That might make you wonder if people grow out it as they reach adulthood. ADHD is a neurodevelopmental disorder that involves difficulties focusing attention (for study or work) and/or sitting still or keeping impulsive actions in check. This means people with ADHD are different and…

Read More

UK firms exploit ADHD medication shortage to push unproven ‘smart’ supplements

Wellness firms are exploiting a national shortage of ADHD medication to push so-called “smart supplements” as an alternative to prescribed drugs. As patients struggle to get hold of medication – or face years-long waits for NHS assessments – companies are peddling unproved products as a “natural” treatment for attention deficit hyperactivity disorder.

Read More

ADHD medication recalled for containing higher-strength tablets than labelled

A medication used to treat attention deficit hyperactivity disorder (ADHD) is being recalled for bottles containing tablets with a higher strength than labelled. The company, JAMP Pharma Corporation, found that some bottles of JAMP Guanfacine extended-release (XR) one-milligram tablets contained four-milligram tablets. One lot, or 100,000 units, is being recalled by the company, Health Canada…

Read More

ADHD Research Roundup: December 15, 2023

In this Research Roundup, we explore new studies on attention-deficit/hyperactivity disorder (ADHD), clinical outcomes of medicinal cannabis therapy as an ADHD treatment, and the connections between ADHD and sleep disturbances, pediatric bipolar disorder, and more.

Read More

Could ADHD be diagnosed genetically?

Despite it being very common, ADHD is often missed until a child reaches age seven or older. By that time, they have likely been struggling socially and in school. Could early genetic testing be part of the solution?

Read More

Prescription Game-Based Therapy Approved for Adolescents With ADHD

The Food and Drug Administration (FDA) has expanded the approval of EndeavorRxⓇ, a prescription-only video game-based digital therapeutic, to include patients aged 13 to 17 years with primarily inattentive or combined-type attention-deficit hyperactivity disorder (ADHD) to improve attention function. Previously, the treatment was only approved for patients aged 8 to 12 years.

Read More

Court Rejects Claims Linking Tylenol to Autism, ADHD

A federal judge dealt a likely fatal blow to hundreds of lawsuits against manufacturers of Tylenol and generic acetaminophen, ruling the plaintiffs don’t have admissible evidence to support claims that using the pain reliever during pregnancy raises a child’s risks of autism or attention-deficit hyperactivity disorder.

Read More

News from Day 2 at the National Academy of Sciences Conference on Adult ADHD

CONFERENCE REPORTER: Day 2 from the National Academy of Sciences brought powerful presentations by the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), American Professional Society of ADHD and Related Disorders (APSARD), Children and Adults with Attention Deficit/Hyperactivity Disorder (CHADD), Attention Deficit Disorder Association (ADDA), and the US Food and Drug…

Read More